Stay updated on Olpasiran Study: Clinical Trial for Lipoprotein(a) Reduction
Sign up to get notified when there's something new on the Olpasiran Study: Clinical Trial for Lipoprotein(a) Reduction page.

Latest updates to the Olpasiran Study: Clinical Trial for Lipoprotein(a) Reduction page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding olpasiran and its clinical trial, while adding a reference to cardiovascular disease and an updated revision number.SummaryDifference5%
- Check30 days agoChange DetectedThe page has updated the publication date for a study on Olpasiran and revised the version number from v2.14.3 to v2.14.4.SummaryDifference0.7%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check66 days agoChange DetectedThe webpage has been updated with new research articles and their publication dates, while previous update dates have been removed.SummaryDifference6%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to Olpasiran Study: Clinical Trial for Lipoprotein(a) Reduction
Enter your email address, and we'll notify you when there's something new on the Olpasiran Study: Clinical Trial for Lipoprotein(a) Reduction page.